Patent · US Active

Modified adenoviruses

US12098383B2 · kind B2 · utility

0Cited by
108References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 4, 2023
Grant dateSep 24, 2024
Priority date—
Expiry dateJan 4, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2840/203
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions include modified adenoviruses. Nucleotides, cells, and methods associated with the compositions, including their use as vaccines. Viral vectors using a TET promoter system and methods of producing viruses having the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.